SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

Clinical trial NCT07141329 · RECRUITING

Trial details

NCT number: NCT07141329
Sponsor: Supernus Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Onset Seizures

Start date: 2025-07-30
Primary completion: 2027-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.